SAFUSIDENIB

UNII:	RCK8KK7SB9
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₅H₁₈Cl₃FN₂O₄
Preferred Substance Name:	SAFUSIDENIB
InChIKey:	BOOMBLZEOHXPPX-BQYQJAHWSA-N
GSRS Full Record:	RCK8KK7SB9 i

1898206-17-1
(2E)-3-[1-[[5-(1-Fluoro-1-methylethyl)-3-(2,4,6-trichlorophenyl)-4-isoxazolyl]carbonyl]-3-methyl-1H-indol-4-yl]-2-propenoic acid
(E)-3-[1-[5-(2-fluoropropan-2-yl)-3-(2,4,6-trichlorophenyl)-1,2-oxazole-4-carbonyl]-3-methylindol-4-yl]prop-2-enoic acid
2-Propenoic acid, 3-[1-[[5-(1-fluoro-1-methylethyl)-3-(2,4,6-trichlorophenyl)-4-isoxazolyl]carbonyl]-3-methyl-1H-indol-4-yl]-, (2E)-
AB-291 free acid
DS-1001 free acid
Safusidenib [WHO-DD]
safusidenib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SAFUSIDENIB

Synonyms and Mappings

Resources